GPT Healthcare Limited (NSE:GPTHEALTH)
India · Delayed Price · Currency is INR 143.13
+0.73 (0.51%)
Jun 1, 2026, 3:29 PM IST
GPT Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 422.21 | 499.22 | 477.69 | 390.08 | 416.63 |
Depreciation & Amortization | 270.88 | 184.58 | 176.68 | 147.84 | 135.31 |
Other Amortization | - | 5.72 | 3.14 | 1.28 | 0.59 |
Loss (Gain) From Sale of Assets | 12.68 | -3.35 | -1.83 | -4.51 | 0.01 |
Asset Writedown & Restructuring Costs | - | - | 2.85 | - | - |
Loss (Gain) From Sale of Investments | -4.87 | -4.01 | -2.9 | -1.79 | -1.93 |
Provision & Write-off of Bad Debts | 26.29 | 39.67 | 18.19 | 4.85 | 1.96 |
Other Operating Activities | 29.41 | -11.78 | 75.87 | 105.51 | 52.78 |
Change in Accounts Receivable | -35.08 | -1.44 | -46.05 | -77.36 | 36.42 |
Change in Inventory | -17.76 | -6.7 | 7.66 | -16.36 | -8.59 |
Change in Accounts Payable | 72.49 | -23.83 | 45.17 | 52.27 | 32.89 |
Change in Other Net Operating Assets | 35.36 | -4.11 | -68.48 | 61.75 | -6.15 |
Operating Cash Flow | 811.61 | 673.96 | 688 | 663.56 | 659.92 |
Operating Cash Flow Growth | 20.42% | -2.04% | 3.68% | 0.55% | 50.23% |
Capital Expenditures | -418.19 | -499.26 | -193.67 | -98.31 | -72.96 |
Sale of Property, Plant & Equipment | 9.71 | 4.89 | 1.51 | 14.61 | 1.79 |
Investment in Securities | -82.78 | 7.37 | -219.23 | -28.72 | -94.86 |
Other Investing Activities | 28.73 | 49.79 | 39.12 | 10.45 | 11.18 |
Investing Cash Flow | -472.52 | -325.92 | -252.06 | 51.53 | -53.39 |
Short-Term Debt Issued | - | 2.17 | 1.5 | - | 14.03 |
Long-Term Debt Issued | 139.63 | 93.97 | - | 2.45 | - |
Total Debt Issued | 139.63 | 96.14 | 1.5 | 2.45 | 14.03 |
Short-Term Debt Repaid | -24.55 | - | - | -13.52 | - |
Long-Term Debt Repaid | -204.02 | -141.46 | -570.65 | -322.53 | -303.09 |
Total Debt Repaid | -228.57 | -141.46 | -570.65 | -336.05 | -303.09 |
Net Debt Issued (Repaid) | -88.94 | -45.33 | -569.15 | -333.6 | -289.06 |
Issuance of Common Stock | - | - | 400 | - | - |
Preferred Dividends Paid | - | - | - | - | -47 |
Common Dividends Paid | -205.14 | -287.19 | -239.71 | -319.62 | -125.59 |
Dividends Paid | -205.14 | -287.19 | -239.71 | -319.62 | -172.59 |
Other Financing Activities | -20.27 | -15.87 | -76.14 | -78.56 | -109.96 |
Financing Cash Flow | -314.34 | -348.39 | -485.01 | -731.78 | -571.61 |
Net Cash Flow | 24.74 | -0.34 | -49.06 | -16.69 | 34.92 |
Free Cash Flow | 393.42 | 174.71 | 494.33 | 565.24 | 586.96 |
Free Cash Flow Growth | 125.19% | -64.66% | -12.55% | -3.70% | 58.87% |
Free Cash Flow Margin | 8.33% | 4.29% | 12.35% | 15.66% | 17.40% |
Free Cash Flow Per Share | 4.80 | 2.13 | 6.17 | 7.07 | 7.35 |
Cash Interest Paid | 20.27 | 15.87 | 51.35 | 78.56 | 109.96 |
Cash Income Tax Paid | 130.28 | 170.81 | 150.2 | 102.9 | 134.92 |
Levered Free Cash Flow | 196.39 | 224.99 | 517.21 | 559.51 | 528.32 |
Unlevered Free Cash Flow | 247.9 | 240.8 | 557.8 | 612.28 | 592.03 |
Change in Working Capital | 55.01 | -36.09 | -61.69 | 20.29 | 54.57 |